胰腺T1信号强度比值作为慢性胰腺炎分期的影像生物标志物
这项多机构前瞻性研究纳入820名参与者,评估胰腺T1信号强度比值(T1评分)作为慢性胰腺炎分期影像生物标志物的价值。结果显示胰腺-脾脏T1评分随慢性胰腺炎机制分期(MSCP 0-6)进展呈线性下降,从MSCP 0的1.34降至MSCP 6的1.05(p < 0.0001),而胰腺-肝脏和胰腺-肌肉T1评分的线性趋势较弱且置信区间更宽。
要点
- 胰腺-脾脏T1评分随MSCP分期0至6进展呈线性下降,MSCP 0为1.34,MSCP 6为1.05。
- 慢性腹痛参与者胰腺-脾脏T1评分均值为1.30,急性或复发性急性胰腺炎为1.22,确诊慢性胰腺炎为1.03。
- 胰腺-肝脏和胰腺-肌肉T1评分的线性趋势较弱且置信区间更宽。
核心结论
- 通过胰腺-脾脏信号强度比值计算的T1评分与慢性胰腺炎进展呈负线性相关,有望作为评估疾病严重程度的实用影像生物标志物用于临床研究和实践。
研究设计与样本
- 前瞻性多机构研究,纳入来自九个临床中心的820名PROCEED研究参与者, enrollment时间为2017年6月至2021年12月;各机构放射科医生采用标准化方法测量胰腺及参考器官(脾脏、椎旁肌肉、肝脏)的T1信号强度并推导T1评分;参与者根据临床病史、MRCP和CT表现按慢性胰腺炎七阶段机制分期(MSCP 0-6)进行分层。
诊断标准与关键数值
- 胰腺-脾脏T1评分均值:MSCP 0为1.34,MSCP 1为1.27,MSCP 2为1.21,MSCP 3为1.16,MSCP 4为1.18,MSCP 5为1.12,MSCP 6为1.05(p < 0.0001);慢性腹痛参与者为1.30,急性或复发性急性胰腺炎为1.22,确诊慢性胰腺炎为1.03。
临床应用与阅片要点
- 作者认为胰腺-脾脏T1评分与慢性胰腺炎进展呈负线性相关,有望作为评估疾病严重程度的实用影像生物标志物用于临床研究和实践。
局限性
- 胰腺-肝脏和胰腺-肌肉T1评分的线性趋势较弱且置信区间更宽。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Our purpose was to validate the T1 SIR (T1 score) as an imaging biomarker for the staging of CP in a large, multi-institutional, prospective study.
METHODS: The prospective study population included 820 participants enrolled in the PROCEED study from nine clinical centers between June 2017 and December 2021. A radiologist at each institution used a standardized method to measure the T1 signal intensity of the pancreas and the reference organs (spleen, paraspinal muscle, liver), which was used to derive respective T1 scores. Participants were stratified according to the seven mechanistic stages of chronic pancreatitis (MSCP 0-6) based on their clinical history, MRCP, and CT findings.
RESULTS: The mean pancreas-to-spleen T1 score was 1.30 in participants with chronic abdominal pain, 1.22 in those with acute or recurrent acute pancreatitis, and 1.03 in definite CP. After adjusting for covariates, we observed a linear, progressive decline in the pancreas-to-spleen T1 score with increasing MSCP from 0 to 6. The mean pancreas-to-spleen T1 scores were 1.34 (MSCP 0), 1.27 (MSCP 1), 1.21 (MSCP 2), 1.16 (MSCP 3), 1.18 (MSCP 4), 1.12 (MSCP 5), and 1.05 (MSCP 6) (p < 0.0001). The pancreas-to-liver and pancreas-to-muscle T1 scores showed less linear trends and wider confidence intervals.
CONCLUSION: The T1 score calculated by SIR of the pancreas-to-spleen shows a negative linear correlation with the progression of chronic pancreatitis. It holds promise as a practical imaging biomarker in evaluating disease severity in clinical research and practice.
引用
- Tirkes, Dasyam, Shah, et al. T1 signal intensity ratio of the pancreas as an imaging biomarker for the staging of chronic pancreatitis. Abdom Radiol (NY). 2022. PMID: 35857066. doi:10.1007/s00261-022-03611-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。